Hypercalcaemia in acromegaly is not always due to men-1

Hypercalcaemia in acromegaly is not always due to men-1

Bibliographic Details
Main Authors:	Zabuliene, L, Tsametis, C, Karavitaki, N, Fazal-Sanderson, V, Turner, H, Wass, J
Format:	Journal article
Published:	2005

Similar Items

Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation?
by: Fernandez, A, et al.
Published: (2008)

Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
by: Karavitaki, N, et al.
Published: (2008)

Acromegaly: Treatment with somatostatin analogs
by: Karavitaki, N, et al.
Published: (2005)

The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly.
by: Karavitaki, N, et al.
Published: (2009)

Pegvisomant: a new treatment modality for acromegaly.
by: Karavitaki, N, et al.
Published: (2004)

The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly.
by: Karavitaki, N, et al.
Published: (2005)

Refractory hypercalcaemia secondary to parathyroid carcinoma: response to high-dose denosumab.
by: Karuppiah, D, et al.
Published: (2014)

New treatments for acromegaly.
by: Wass, J, et al.
Published: (1998)

Acute octreotide suppression test (100 mu g sc): a valuable tool for predicting the long-term response to the long-acting somatostatin analogs in patients with active acromegaly
by: Karavitaki, N, et al.
Published: (2005)

A comparison of lanreotide and octreotide LAR for treatment of acromegaly.
by: Turner, H, et al.
Published: (1999)

Reduction of elevated IGF-1 levels in coincident amyotrophic lateral sclerosis and acromegaly.
by: Pereira, E, et al.
Published: (2010)

Evidence for the effectiveness of radiotherapy in the treatment of acromegaly.
by: Wass, J
Published: (1997)

Long-term effects of radiotherapy for acromegaly.
by: Wass, J
Published: (1996)

Radiotherapy in acromegaly: a protagonists viewpoint.
by: Wass, J
Published: (2003)

AIP Mediates the Effects of Somatostatin Analogues in Acromegaly - Evidence from Clinical and Experimental Studies.
by: Chahal, H, et al.
Published: (2010)

Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly.
by: Turner, H, et al.
Published: (2004)

Investigation protocol: acromegaly and its investigation.
by: Duncan, E, et al.
Published: (1999)

Radiation-induced hypopituitarism.
by: Fernandez, A, et al.
Published: (2009)

Two underlying diseases causing hypercalcaemia?
by: Pazianas, M, et al.
Published: (2002)

Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
by: Wass, J
Published: (2003)

Two underlying diseases causing hypercalcaemia? (multiple letters) [1]
by: Pazianas, M, et al.
Published: (2002)

Clinical MEN-1 among a large cohort of patients with acromegaly
by: Nachtigall, LB, et al.
Published: (2020)

Depot-bromocriptine treatment for prolactinomas and acromegaly.
by: Grossman, A, et al.
Published: (1986)

DEPOT BROMOCRIPTINE IN THE TREATMENT OF PROLACTINOMAS AND ACROMEGALY
by: Grossman, A, et al.
Published: (1985)

Somatostatin Analogue Treatment Increases AIP Protein Expression in Somatotroph Tumours from Patients with Acromegaly and in GH3 Cells in vitro.
by: Chahal, H, et al.
Published: (2011)

Effect of Pentadecapeptide BPC 157 on Hypercalcaemia in Rats
by: Matej Lacković, et al.
Published: (2023-01-01)

An uncanny case of paraneoplastic calcitriol mediated hypercalcaemia
by: Preet Mukesh Shah, et al.
Published: (2023-06-01)

“The cat and the calcium”. A case of delirium secondary to hypercalcaemia.
by: T. Jiménez Aparicio, et al.
Published: (2023-03-01)

Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly.
by: Turner, H, et al.
Published: (1999)

Acromegaly, colonic polyps and carcinoma.
by: Jenkins, P, et al.
Published: (1997)

Guidelines for acromegaly management.
by: Melmed, S, et al.
Published: (2002)

The pathology of median neuropathy in acromegaly.
by: Jenkins, P, et al.
Published: (2000)

Acromegaly or chronic renal failure: a diagnostic dilemma.
by: Wong, N, et al.
Published: (1997)

Severe hypercalcaemia from secretion of parathyroid hormone-related peptide.
by: Barakat, M, et al.
Published: (2004)

Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience.
by: Ahmed, S, et al.
Published: (1999)

Calcium-sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pancreatitis.
by: Pearce, S, et al.
Published: (1996)

Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
by: Yap, L, et al.
Published: (2002)

Criteria for cure of acromegaly: a consensus statement.
by: Giustina, A, et al.
Published: (2000)

Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
by: Wass, J
Published: (1997)

Anaesthetic Implications in Primary Hyperparathyroidism with Severe Hypercalcaemia: a Case Report
by: Pranav Bansal, et al.
Published: (2013-07-01)